Prestige Consumer Healthcare
PBH
Prestige Consumer Healthcare (PBH) earnings history
Most recent quarter
- Fiscal period
- Q1 2027
- Period end
- Jun 30, 2026
- EPS actual
- $0.98
- EPS estimate
- $0.88
- EPS surprise
- +11.19%
- Revenue surprise
- +6.14%
- Revenue
- $265.7M
- Revenue estimate
- $250.3M
- Reported
- Aug 6, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q1 2027 | Aug 6, 2026 | $0.88 | $0.98 | +11.19% | $265.7M | SEC |
| Q4 2026 | May 13, 2026 | $1.39 | $1.23 | −11.51% | $281.6M | SEC |
| Q3 2026 | Feb 5, 2026 | $1.14 | $1.14 | −0.39% | $283.4M | SEC |
| Q2 2026 | Nov 6, 2025 | $0.97 | $1.07 | +10.35% | $274.1M | SEC |
| Q1 2026 | Aug 7, 2025 | $1.00 | $0.95 | −4.99% | $249.5M | SEC |
| Q4 2025 | May 8, 2025 | $1.30 | $1.32 | +1.66% | $296.5M | SEC |
| Q3 2025 | Feb 6, 2025 | $1.18 | $1.22 | +3.82% | $290.3M | SEC |
| Q2 2025 | Nov 7, 2024 | $1.08 | $1.09 | +0.50% | $283.8M | SEC |
| Q1 2025 | Aug 8, 2024 | $0.86 | $0.90 | +4.72% | $267.1M | SEC |
| Q4 2024 | May 14, 2024 | $1.14 | $1.02 | −10.46% | $277.0M | SEC |
| Q3 2024 | Feb 8, 2024 | $1.04 | $1.06 | +1.83% | $282.7M | SEC |
| Q2 2024 | Nov 2, 2023 | $1.07 | $1.07 | +0.25% | $286.3M | SEC |
| Q1 2024 | Aug 3, 2023 | $1.01 | $1.06 | +5.01% | $279.3M | SEC |
| Q4 2023 | May 4, 2023 | $1.04 | $1.07 | +2.90% | $285.9M | SEC |
| Q3 2023 | Feb 2, 2023 | $1.01 | $1.04 | +2.77% | $275.5M | SEC |
| Q2 2023 | Nov 3, 2022 | $1.00 | $1.02 | +1.83% | $289.3M | SEC |
| Q1 2023 | Aug 4, 2022 | $1.04 | $1.09 | +4.98% | $277.1M | SEC |
| Q4 2022 | May 5, 2022 | $0.89 | $0.91 | +2.63% | $266.9M | SEC |
| Q3 2022 | Feb 3, 2022 | $0.88 | $0.99 | +12.08% | $274.5M | SEC |
| Q2 2022 | Nov 4, 2021 | $0.99 | $1.02 | +3.37% | $276.2M | SEC |
Quarterly revenue
Frequently asked questions
When did Prestige Consumer Healthcare (PBH) last report earnings?
Prestige Consumer Healthcare last reported on Aug 6, 2026, covering fiscal Q1 2027.
Did PBH beat earnings estimates?
Yes. Prestige Consumer Healthcare reported EPS of $0.98 for Q1 2027 against a $0.88 estimate — a 11.19% beat.
How much revenue did PBH report last quarter?
Prestige Consumer Healthcare reported $265.7M in revenue for Q1 2027, against a consensus estimate of $250.3M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.